Lipophilicity Relationships in Inhibitors of CYP2C9 and CYP2C19 Enzymes

By Lewis David F.V.   Lake Brian G.   Ito Yuko   Dickins Maurice  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 385-389

Informa Healthcare

Access to resources Recommend Favorite

Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure

By Lewis D. F. V.  

Xenobiotica, Vol. 32, Iss. 4, 2002-04 ,pp. : 305-323

Informa Healthcare

Access to resources Recommend Favorite

CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification

By Hu Y.   Krausz K.   Gelboin H. V.   Kupfer D.  

Xenobiotica, Vol. 34, Iss. 2, 2004-02 ,pp. : 117-132

Informa Healthcare

Access to resources Recommend Favorite

Identification of Residues 286 and 289 as Critical for Conferring Substrate Specificity of Human CYP2C9 for Diclofenac and Ibuprofen

By Klose T.S.   Ibeanu G.C.   Ghanayem B.I.   Pedersen L.G.   Li L.   Hall S.D.   Goldstein J.A.  

Archives of Biochemistry and Biophysics, Vol. 357, Iss. 2, 1998-09 ,pp. : 240-248

Elsevier

Access to resources Recommend Favorite

Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide, S-Mephenytoin, and Omeprazole Hydroxylations

By Lasker J.M.   Wester M.R.   Aramsombatdee E.   Raucy J.L.  

Archives of Biochemistry and Biophysics, Vol. 353, Iss. 1, 1998-05 ,pp. : 16-28

Elsevier

Access to resources Recommend Favorite